Cardio-Oncology
Showing 1 - 25 of 3,187
Hematopoietic Stem Cell Transplant Trial in Ann Arbor (Cardio-oncology program)
Not yet recruiting
- Hematopoietic Stem Cell Transplant
- Cardio-oncology program
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Jul 6, 2023
Breast Cancer, Hematologic Malignancy, Immune Checkpoint Inhibitor-Related Myocarditis Trial in Weston (anonymized data
Recruiting
- Breast Cancer
- +4 more
- anonymized data collection during programmed surveillance clinical follow up
-
Weston, FloridaCleveland Clinic Florida
Oct 27, 2022
Cancer Trial in Los Angeles (Cardiac Aggressive Risk MitigAtion Plan)
Recruiting
- Cancer
- Cardiac Aggressive Risk MitigAtion Plan
-
Los Angeles, CaliforniaCancer Clinical Trials Office
Jan 10, 2023
Understanding CARdiac Events in Breast Cancer
Recruiting
- Breast Cancer
- +5 more
-
Galway, Ireland
- +3 more
Jun 27, 2023
Atrial Fibrillation Trial in Caen (Insertable subcutaneous cardiac monitor (BIOMONITOR IIIm®, Biotronik®))
Not yet recruiting
- Atrial Fibrillation
- Insertable subcutaneous cardiac monitor (BIOMONITOR IIIm®, Biotronik®)
-
Caen, Normandie, FranceCaen University Hospital, Department of Pharmacology
Sep 6, 2023
Heart Failure Trial in Melbourne (Heart Failure intervention (Cardio-Oncology Disease Management Plan (CO-DMP), Usual care)
Recruiting
- Heart Failure
- Heart Failure intervention (Cardio-Oncology Disease Management Plan (CO-DMP)
- Usual care
-
Melbourne, Victoria, AustraliaBaker Heart and Diabetes Institute
Jun 27, 2022
Chemotherapy-induced Cardiotoxicity.
Recruiting
- Cardiotoxicity
- +2 more
- Blood sampling
- +4 more
-
Prague, Czechia
- +1 more
Aug 15, 2023
Breast Cancer, Tumor, Breast, Breast Diseases Trial in Poland (Sacubitril-valsartan)
Not yet recruiting
- Breast Cancer
- +12 more
-
Opole, Opolskie, Poland
- +3 more
Jul 15, 2022
Survivorship, Stem Cell Transplant Complications Trial (Technology supported, coordinated survivorship care using wearable
Not yet recruiting
- Survivorship
- Stem Cell Transplant Complications
- Technology supported, coordinated survivorship care using wearable devices, supportive patient-apps and cardio-oncology physician apps
- (no location specified)
Nov 8, 2021
Heart Failure, Cardiotoxicity, Cancer Trial (Cardio-oncology Rehabilitation (CORE), PAI Group (PAI), Exercise Guidelines for
Not yet recruiting
- Heart Failure
- +2 more
- Cardio-oncology Rehabilitation (CORE)
- +2 more
- (no location specified)
Aug 19, 2021
Circulating Tumor Cells Before and After Thoracic Resection With
Recruiting
- Thoracic Surgery
- Cardiopulmonary Bypass
- Resection with intraoperative use of ECMO/CPB
- Resection without intraoperative use of ECMO/CPB
-
Milan, ItalyEuropean Institue of Oncology
Jan 11, 2022
Heart Failure, Cardiotoxicity, Cancer Trial (Cardio-oncology Rehabilitation (CORE), Support, Passive Behavioural Support)
Not yet recruiting
- Heart Failure
- +2 more
- Cardio-oncology Rehabilitation (CORE)
- +2 more
- (no location specified)
Oct 18, 2020
Cancer, Cardiac Disease, Metabolic Syndrome Trial in Paris (No interventions are planned)
Recruiting
- Cancer
- +4 more
- No interventions are planned
-
Paris, FranceAssistance Publique Hôpitaux de Paris - Centre Université de Par
May 25, 2020
New Echocardiographic Indicators in Treatment of Primary
Not yet recruiting
- Multiple Myeloma
- Chemotherapy and/or autologous hematopoietic stem cell transplantation
- (no location specified)
Sep 18, 2023
NSCLC Trial in Worldwide (Entrectinib, Crizotinib)
Recruiting
- Carcinoma, Non-Small-Cell Lung
-
Barretos, SP, Brazil
- +66 more
Jan 27, 2023
Small Cell Lung Carcinoma Trial in Worldwide (Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody, Carboplatin,
Completed
- Small Cell Lung Carcinoma
- Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
- +3 more
-
Fort Myers, Florida
- +113 more
Nov 30, 2022
Renal Cell Carcinoma, Bladder Cancer, MSI-H Cancer Trial in Paris (Arterial Doppler for Flow Mediated Reserve measurement)
Recruiting
- Renal Cell Carcinoma
- +3 more
- Arterial Doppler for Flow Mediated Reserve measurement
-
Paris, FranceINstitut Mutualiste Montsouris
Aug 29, 2023
NSCLC Trial in Worldwide (Alectnib, Cisplatin, Vinorelbine)
Active, not recruiting
- Carcinoma, Non-Small-Cell Lung
- Alectnib
- +5 more
-
Chicago, Illinois
- +140 more
Jan 20, 2023
Non-Small-Cell Lung Trial in Worldwide (Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody, Placebo Comparator,
Active, not recruiting
- Non-Small-Cell Lung
- Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
- +6 more
-
Tucson, Arizona
- +128 more
Nov 10, 2022
Cancer Patients and Their Relatives
Recruiting
- Malignant Neoplasm
- Biospecimen Collection
- Questionnaire Administration
-
Phoenix, Arizona
- +41 more
Sep 14, 2022
Heart Failure Trial in Tel Aviv (ACE inhibitors, beta blockers)
Recruiting
- Heart Failure
- ACE inhibitors
- beta blockers
-
Tel Aviv, IsraelTel Aviv Medical Center
Feb 1, 2022
Preventing and Treating Cardiotoxicity Induced by Anticancer
Recruiting
- Cardiovascular Complication
- +7 more
- Anti-Cancer Agents
-
Paris, France
- +2 more
Sep 24, 2019
NSCLC (NSCLC) Trial in Worldwide (Atezolizumab, Tiragolumab, Durvalumab)
Recruiting
- Non-small Cell Lung Cancer (NSCLC)
- Atezolizumab
- +2 more
-
Tempe, Arizona
- +254 more
Aug 8, 2022
Small Cell Lung Carcinoma Trial in Italy (Atezolizumab, Carboplatin, Etoposide)
Active, not recruiting
- Small Cell Lung Carcinoma
- Atezolizumab
- +2 more
-
Rionero In Vulture (PZ), Basilicata, Italy
- +24 more
Dec 12, 2022